Article EMA Thank You New MHRA Windsor Framework documents guide post-Brexit flow of medicines for U.K., Great Britain, and the E.U.
Agency IQ
AUGUST 4, 2023
Articles 3(1) and 3(2) of the current European pharmaceutical regulation (EC) No 726/2004 set out requirements for medicinal products that must use the centralized procedure, rather than national approval pathways. These features should not be included on outer packaging or immediate packaging, if there is no outer packaging.
Let's personalize your content